Journal Article

DKFZ-2019-02953

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.

Wagner, N. B. (First author)DKFZ* ; Weide, B. ; Gries, M.DKFZ* ; Reith, M.DKFZ* ; Tarnanidis, K.DKFZ* ; Schuermans, V.DKFZ* ; Kemper, C.DKFZ* ; Kehrel, C.DKFZ* ; Funder, A.DKFZ* ; Lichtenberger, R.DKFZ* ; Sucker, A. ; Herpel, E. ; Holland-Letz, T.DKFZ* ; Schadendorf, D. ; Garbe, C. ; Umansky, V.DKFZ* ; Utikal, J.DKFZ* ; Gebhardt, C. (Last author)DKFZ*

2019
BioMed Central London

This record in other databases:  

Please use a persistent id in citations: doi:10.1186/s40425-019-0828-1

Abstract: Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.

---

Contributing Institute(s):

1. Biostatistik (C060)
2. KKE Dermatoonkologie (A370)

Research Program(s):

1. 311 - Signalling pathways, cell and tumor biology (POF3-311) (POF3-311)

Appears in the scientific report 2019

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---